Royal London Asset Management Ltd. grew its stake in Davita Inc (NYSE:DVA) by 4.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 57,221 shares of the company’s stock after acquiring an additional 2,492 shares during the quarter. Royal London Asset Management Ltd.’s holdings in Davita were worth $2,882,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in DVA. Quantamental Technologies LLC purchased a new position in shares of Davita in the 4th quarter valued at $34,000. Honkamp Krueger Financial Services Inc. purchased a new position in shares of Davita in the 3rd quarter valued at $143,000. Atlas Capital Advisors LLC increased its holdings in shares of Davita by 247.9% in the 3rd quarter. Atlas Capital Advisors LLC now owns 2,592 shares of the company’s stock valued at $188,000 after acquiring an additional 1,847 shares during the period. Contravisory Investment Management Inc. increased its holdings in shares of Davita by 8.2% in the 4th quarter. Contravisory Investment Management Inc. now owns 3,932 shares of the company’s stock valued at $202,000 after acquiring an additional 298 shares during the period. Finally, Captrust Financial Advisors boosted its position in shares of Davita by 96.8% in the 3rd quarter. Captrust Financial Advisors now owns 3,050 shares of the company’s stock worth $218,000 after purchasing an additional 1,500 shares in the last quarter. Institutional investors and hedge funds own 84.66% of the company’s stock.
A number of analysts have recently weighed in on DVA shares. Deutsche Bank started coverage on Davita in a research report on Thursday, January 3rd. They issued a “buy” rating and a $60.00 price objective for the company. TheStreet cut Davita from a “b-” rating to a “c+” rating in a research report on Thursday, November 8th. Zacks Investment Research cut Davita from a “buy” rating to a “hold” rating in a research report on Tuesday, October 23rd. ValuEngine cut Davita from a “buy” rating to a “hold” rating in a research report on Wednesday, October 17th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $65.00 price target on shares of Davita in a research report on Wednesday, January 9th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company. Davita presently has a consensus rating of “Hold” and a consensus target price of $71.93.
Davita (NYSE:DVA) last issued its quarterly earnings data on Wednesday, November 7th. The company reported $0.56 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.89 by ($0.33). The company had revenue of $2.85 billion during the quarter, compared to analyst estimates of $2.93 billion. Davita had a net margin of 5.39% and a return on equity of 13.87%. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period last year, the firm earned $0.81 EPS. As a group, equities research analysts expect that Davita Inc will post 3.56 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Royal London Asset Management Ltd. Has $2.88 Million Stake in Davita Inc (DVA)” was originally published by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.themarketsdaily.com/2019/02/07/royal-london-asset-management-ltd-has-2-88-million-stake-in-davita-inc-dva.html.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading: Technical Analysis of Stocks and What It Means
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.